Low Dose Enteric Pathogens
Publications related to low dose enteric pathogens by MARCE participants.
-
Bushen OY, Kohli A, Pinkerton RC, Dupnik K, Newman RD, Sears CL, Fayer R, Lima AA, and Guerrant RL: Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg 2007, 101: 378-384 PubMed link
-
Keepers TR, Psotka MA, Gross LK, and Obrig TG: A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 2006, 17: 3404-3414 PubMed link
-
Levine MM, Kotloff KL, Barry EM, Pasetti MF, and Sztein MB: Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 2007, 5: 540-553 PubMed link
-
Parr JB, Sevilleja JE, Amidou S, Alcantara C, Stroup SE, Kohli A, Fayer R, Lima AA, Houpt ER, and Guerrant RL: Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction. Am J Trop Med Hyg 2007, 76: 938-942 PubMed link
-
Roberts SB, Mazurie AJ, and Buck GA: Integrating genome-scale data for gene essentiality prediction. Chem Biodivers 2007, 4: 2618-2630 PubMed link
-
Roche JK, Keepers TR, Gross LK, Seaner RM, and Obrig TG: CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 2007, 170: 526-537 PubMed link
-
Salerno-Goncalves R and Sztein MB: Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol 2006, 14: 536-542 PubMed link